ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.16%
      US Tech 100
      19,107.20
      -1.02%
      Dow Jones
      40,358.09
      -0.14%
      Brent Oil
      80.635
      -0.17%
      Bitcoin
      65,828.93
      -0.14%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Genus Plc (GNS) Quote

      Genus Plc

      Genus Plc (GNS)

      Genius Group Limited
      1,640.00
      -4.00
      (-0.24%)
      Closed July 23 11:30AM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      1,640.00
      Bid
      1,636.00
      Ask
      1,648.00
      Volume
      73,115
      1,634.00 Day's Range 1,660.00
      1,478.00 52 Week Range 2,544.00
      Market Cap
      1.083B
      Previous Close
      1,644.00
      Open
      1,640.00
      Last Trade
      12205
      @
      1640
      (UT)
      Last Trade Time
      Financial Volume
      1,200,623p
      VWAP
      1,642.1023
      Average Volume (3m)
      108,167
      Shares Outstanding
      66,031,509
      Dividend Yield
      1.95%
      PE Ratio
      32.52
      Earnings Per Share (EPS)
      0.5
      Revenue
      689.7M
      Net Profit
      33.3M

      About Genus Plc

      Sector
      Coml Physical, Biologcl Resh
      Industry
      Chemicals Diversified
      Website
      www.genusplc.com
      Headquarters
      Hampshire, Gbr
      Founded
      1994
      Genus Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GNS. The last closing price for Genus was 1,644p. Over the last year, Genus shares have traded in a share price range of 1,478.00p to 2,544.00p.

      Genus currently has 66,031,509 shares outstanding. The market capitalization of Genus is £1.09 billion. Genus has a price to earnings ratio (PE ratio) of 32.52.

      GNS Latest News

      More News

      Genus to meet profit expectations amid downgraded outlook

      Genus PLC on Wednesday said the company is on track to meet market expectations in financial 2024, despite challenges ...

      July 17 2024
      Alliance News

      Genus PLC Trading Update

      Genus PLC 17 July 2024   17 July 2024     Genus plc Trading Update ("Genus" or the "Group")   Genus (LSE: GNS), a leading global animal genetics company, publishes the following unaudited...

      July 17 2024
      RNS Regulatory News

      Genus PLC Holding(s) in Company

      Genus PLC 03 June 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0002074580 Issuer Name GENUS PLC UK or Non-UK Issuer UK 2. Reason for Notification An...

      June 03 2024
      RNS Regulatory News

      Genus PLC Total Voting Rights

      Genus PLC 01 May 2024   1 May 2024 Genus plc Total Voting Rights Genus plc (LSE: GNS) announces that, as at 30 April 2024, its issued share capital consists of 66,032,782 ordinary shares of...

      May 01 2024
      RNS Regulatory News

      Genus touts programme to boost investment returns as profit declines

      Genus PLC on Thursday reported a profit fall as its dairy business in China was "particularly" challenged, but said i ...

      February 22 2024
      Alliance News

      *Genus expects FY24 adjusted pretax profit to be not less than GBP58m

      ...

      February 22 2024
      Alliance News

      *Genus interim dividend of 10.3p per share unchanged YoY

      ...

      February 22 2024
      Alliance News

      *Genus H1 FY24 pretax profit GBP14.3m vs GBP15.0m YoY

      ...

      February 22 2024
      Alliance News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-238-12.673056443187819041628956421713.36882959DE
      4-80-4.6511627907172019041626942951711.54039891DE
      12-140-7.865168539331780191816261081671773.06268462DE
      26-574-25.92592592592214237814781134901832.23362151DE
      52-868-34.60925039872508254414781321192034.29807845DE
      156-3580-68.58237547895220625014781136432894.02576332DE
      260-1024-38.43843843842664625014781125843268.02182593DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      DCAPUnity Wealth Partners Dynamic Capital Appreciation & Options ETF
       20.10
      (839.25%)
      		128.82k
      RGCRegencell Bioscience Holdings Ltd
      $ 15.15
      (349.55%)
      		1.34M
      ATPCAgape ATP Corporation
      $ 0.2262
      (58.18%)
      		107.31M
      SLRXSalarius Pharmaceuticals Inc
      $ 2.34
      (51.95%)
      		60.04M
      GSUNGolden Sun Health Technology Group Ltd
      $ 7.46
      (45.42%)
      		589.98k
      FLYEFly E Group Inc
      $ 1.1601
      (-81.82%)
      		25.44M
      RNAZTransCode Therapeutics Inc
      $ 0.3035
      (-61.70%)
      		9.78M
      JAGXJaguar Health Inc
      $ 1.755
      (-58.90%)
      		15.47M
      MIRAMIRA Pharmaceuticals Inc
      $ 2.55
      (-49.10%)
      		25.64M
      IVPInspire Veterinary Partners Inc
      $ 5.19
      (-43.83%)
      		1.67M
      SLNASelina Hospitality PLC
      $ 0.026
      (-29.73%)
      		220.18M
      SPWRSunPower Corporation
      $ 0.9514
      (32.91%)
      		186.75M
      NVDANVIDIA Corporation
      $ 122.59
      (-0.77%)
      		173.87M
      ADILAdial Pharmaceuticals Inc
      $ 1.3422
      (26.62%)
      		160.04M
      HOLOMicroCloud Hologram Inc
      $ 0.588
      (26.07%)
      		135.53M

      Discussion

      View Full Feed
      SSKILLZ1 SSKILLZ1 29 seconds ago
      that is tonkin I come to know and love. he stinks. On a positive note mcneil has started to figure out how to hit again.
      dmb2 dmb2 30 seconds ago
      Gary, I agree that more intelligent latitude can be applied to the approval process knowing patient safety is the primary goal. If a drug is the best available treatment in a life threatening disease and has a benign safety profile, it is logical and humane to do better at making it available. Today
      NWBO
      Walter4 Walter4 2 minutes ago
      https://youtu.be/W0wU3Zb3S50?si=UThyqp0iBG8PfuPb
      SONG
      zab zab 2 minutes ago
      You are not in control of this forum, you can post, but that's it.
      fuagf fuagf 2 minutes ago
      LOL Broccoli is great, just on a plate, not in a cake.
      oystersnbeer oystersnbeer 2 minutes ago
      Say it ,
      KA-MA-LA,
      KA-MA-LA..... PRES-I-DENT!!

      https://x.com/ananavarro/status/1815791797085557055
      gorbec1 gorbec1 2 minutes ago
      Maybe we switching to new company
      MCIC
      cadillacdave cadillacdave 3 minutes ago
      Sorry but "low risk, no reward" equates with a waste of time, worthless venture etc. No one is mischaracterizing what you said - I put it in quotes.

      Try to explain it away, but you are getting deeper into the quicksand. Those were your words and that is the plain meaning of it.
      WDDD
      m$teamworkotc m$teamworkotc 3 minutes ago
      californification.hang 10 baby........LFG Jim....copper-silver...m team needs a new Z06
      VXIT
      dukeb dukeb 3 minutes ago
      This company should have been shut down 10 years ago. They had no viable product. The revenue the company brought in was dwarfed by the 6 figure salaries of the 3 top executives and that situation only got worse as the years went by.

      There were red flags a plenty and anyone with com
      ZRFY
      OMOLIVES OMOLIVES 3 minutes ago
      Skenes pitching into the 9th. Tied game.
      mc73 mc73 3 minutes ago
      If one were to assume anything...it would be to assume this company is going bye-bye. Well, at least that is what I assume. I will keep my eye out and jump back in if things look promising.
      RSPI
      Anshu2 Anshu2 4 minutes ago
      That’s a junk/nothing report. More importantly, he hasn’t changed his stance or given justification for his continued belief in the company — after multiple trial failures since the 2022 report.

      I sure hope that the current rise in the stock has very little to do with Kolbert’s cover
      AVXL
      JustMe JustMe 4 minutes ago
      Nope! I bought some AMC and GME to keep me occupied.

      GO RNVA!!!
      AMC GME RNVA
      Barron4664 Barron4664 4 minutes ago
      Thanks Rodney. My analysis stands. The 10% coupon was offered to Treasury, not agreed to in the SPSPA. Every one of the conditions in that fact sheet was agreed to and was signed by the Director of FHFA and the Secretary of Treasury with the exception of the coupon rate of 10% and or 12% in kind. No
      FNMA
      TheKid5 TheKid5 5 minutes ago
      The growing anticipation is palatable and the masses are getting hugely excited for CLNV!!!🤑
      CLNV
      BoscoLives21 BoscoLives21 5 minutes ago
      Sure jump to a different point! Four Awards at the 2024 NY Int’l Beer Competition, yea or nay?

      https://nyibeercompetition.com/winners/2024-winners/

      $KEGS
      KEGS
      Diamondhands45 Diamondhands45 5 minutes ago
      Shouldn’t be long then fir the Q
      KATX
      JH Mcdough JH Mcdough 5 minutes ago
      We’re do you stand on this now ? Still think it’s gonna be a runner or did the ball get dropped on us ?
      PPJE
      SSKILLZ1 SSKILLZ1 5 minutes ago
      You see now you tag hopefully mcniel watched that. Vientos couldn't of hit that ball much harder.
      JH Mcdough JH Mcdough 6 minutes ago
      Is there any chance this recovers or is it dead now ?
      PPJE
      LCP77 LCP77 7 minutes ago
      Okay dude. They can use that! Just post bids enough to pull it off. You’ll be giving wallstreet a riskless 10% return. Got an extra $10,000,000 to make stuff happen?
      NB
      JH Mcdough JH Mcdough 7 minutes ago
      I’ll start out by saying I like CNNA first and for most but how is it going to trade when it’s out of EM and the MMs get their hands on it . Also it’s been in EM for over a year now . That is a very long time to be there with out any action .
      CNNA
      Alley-oop Alley-oop 7 minutes ago
      Huge run is on the way. Buckle up tight!
      SMCE

      Your Recent History

      LSE
      GNS
      Genus
      HUOB
      QOMUSDT
      Shiba Predator
      NASDAQ
      AAXFIXX
      Bofa Finance Llc Issuer ...
      NASDAQ
      DISHR
      DISH Network
      Delayed Upgrade Clock